https://orcid.org/0000-0002-7855-9838
References
- Wako Z, Mengistu D, Dinegde NG, et al. Adherence to adjuvant hormonal therapy and associated factors among women with breast cancer attending the Tikur Anbessa specialized hospital, Addis Ababa Ethiopia, 2019: a Cross-sectional Study. Breast Cancer. 2021;13:383–392.
- Felder TM, Heiney SP, Hebert JR, et al. Improving adherence to adjuvant hormonal therapy among disadvantaged women diagnosed with breast cancer in South Carolina: proposal for a Multimethod Study. JMIR Res Protoc. 2020;9(9):e17742. doi:10.2196/17742
- Sella T, Chodick G. Adherence and persistence to adjuvant hormonal therapy in early-stage breast cancer patients: a population-based retrospective cohort study in Israel. Breast Care. 2020;15(1):45–54. doi:10.1159/000500318
- Farias AJ, Hansen RN, Zeliadt SB, Ornelas IJ, Li CI, Thompson B. Factors associated with adherence to adjuvant endocrine therapy among privately insured and newly diagnosed breast cancer patients: a quantile regression analysis. J Managed Care Spec Pharm. 2016;22(8):969–978. doi:10.18553/jmcp.2016.22.8.969
- Brito C, Portela MC, de Vasconcellos MT. Adherence to hormone therapy among women with breast cancer. BMC Cancer. 2014;14(1):1–8. doi:10.1186/1471-2407-14-397
- Andaleeb SS. Service quality perceptions and patient satisfaction: a study of hospitals in a developing country. Soc Sci Med. 2001;52(9):1359–1370. doi:10.1016/S0277-9536(00)00235-5
- Bekele F, Fekadu G, Bekele K, Dugassa D, Sori J. Drug-related problems among patients with infectious disease admitted to medical wards of Wollega University Referral Hospital: prospective observational study. SAGE Open Med. 2021;9:2050312121989625. doi:10.1177/2050312121989625